Lunit to supply AI cancer diagnostics to Qatar

Lunit Inc., a South Korean cancer diagnostics AI company, announced on Monday that it will provide its AI breast cancer screening solution Lunit Insight MMG for Qatar's Primary Health Care Corp. (PHCC)-led National Breast Cancer Screening Project.

Qatar's PHCC recommends women aged between 45 and 69 undergo breast cancer screening every three years through the national breast cancer screening program.

With this supply contract, Lunit's AI solution will be part of Qatar's national breast cancer screening process.

Two specialized radiologists will each interpret the mammography images, referring to the analysis results from Lunit Insight MMG.

Write to Jeong Min Nam at peux@hankyung.com